Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2000-12-19
2004-12-28
Brumback, Brenda (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120, C530S351000
Reexamination Certificate
active
06835544
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to receptor proteins, DNA sequences encoding same, and various uses therefor.
BACKGROUND OF THE INVENTION
Activins are dimeric proteins which have the ability to stimulate the production of follicle stimulating hormone (FSH) by the pituitary gland. Activins share a common subunit with inhibins, which inhibit FSH secretion.
Activins are members of a superfamily of polypeptide growth factors which includes the inhibins, the transforming growth factors-&bgr; (TGF-&bgr;), Mullerian duct inhibiting substance, the
Drosophila decapentaplegic
peptide, several bone morphogenetic proteins, and the Vg-related peptides.
As a result of their extensive anatomical distribution and multiple biological actions, members of this superfamily of polypeptide growth factors are believed to be involved in the regulation of numerous biological processes. Activin, for example, is involved in the proliferation of many tumor cell lines, the control of secretion and expression of the anterior pituitary hormones (e.g., FSH, GH and ACTH), neuron survival, hypothalamic oxytocin secretion, erythropoiesis, placental and gonadal steroidogenesis, early embryonic development, and the like.
Other members of the activin/TGF-&bgr; superfamily of polypeptide growth factors are involved in the regulation of cell function and cell proliferation for numerous cell types, in adults and embryos. For example, cells which are subject to regulation by one or more members of the activin/TGF-&bgr; superfamily of polypeptide growth factors include mesenchymal cells, muscle cells, skeletal cells, immune cells, hematopoietic cells, steroidogenic cells, endothelial cells, liver cells, epithelial cells, and the like.
Chemical cross-linking studies with a number of cell types suggests that multiple binding sites (i.e., receptors) exist on the surface of cells. However, little is known about the structure of these receptors, or about the second messenger signalling systems that they employ. It would be desirable, therefore, if the nature of these poorly characterized receptor proteins could be more fully understood.
BRIEF DESCRIPTION OF THE INVENTION
In accordance with the present invention, we have identified and characterized members of a new superfamily of receptor proteins which comprise three distinct domains: an extracellular, ligand-binding domain, a hydrophobic, trans-membrane domain, and an intracellular, receptor domain having serine kinase-like activity.
Also provided are DNAs encoding the above-described receptor proteins, and antibodies thereto, as well as bioassays, therapeutic compositions containing such proteins and/or antibodies, and applications thereof.
The DNAs of the invention are useful as probes for the identification of additional members of the invention superfamily of receptor proteins, and as coding sequences which can be used for the recombinant expression of the invention receptor proteins, or functional fragments thereof. The invention receptor proteins, and antibodies thereto, are useful for the diagnosis and therapeutic management of carcinogenesis, wound healing, disorders of the immune, reproductive, or central nervous systems, and the like.
REFERENCES:
patent: 5538892 (1996-07-01), Donahoe et al.
patent: 5614609 (1997-03-01), Ib a nez et al.
Kondo et al, Identification of the two types of specific receptor for activin/EDF expressed on Friend leukemia and embryonal carcinoma cells. Biochem. Biophys. Res. Commun. 161:1267-1272, 1989.*
Campen et al, Characterization of activin A binding sites on the human leukemia cell line K562. Biochem. Biophys. Res. Commun. 157: 844-849, 1988.*
Konno, Y., et al. Enzymatic properties of a novel Phorbol ester receptor/Protein Kinase, nPKC. J. Biochem. (Tokyo) 106(4):673-678, 1989.*
Beckmann and Kadesch, “The leucine zipper of TFE3 dictates helix-loop-helix dimerization specificity”Genes&Development5:1057-1066 (1991).
Blackwell and Weintraub, “Differences and Similarities in DNA-Binding Preferences of MyoD and E2A Protein Complexes Revealed by Binding Site Selection”Science250:1104-1110 (1990).
Campen and Vale, “Characterization of Activin a Binding Sites on the Human Leukemia Cell Line K562”Biochem. Biophys. Res. Comm.157(2):844-849 (1988).
Càrcamo et al., “Type I Receptors Specify Growth-Inhibitory and Transcriptional Responses to Transforming Growth Factor &bgr; and Activin”Molecular and Cellular Biology14(6):3810-3821 (1994).
Centrella et al., “Activin-A Binding and Biochemical Effects in Osteoblast-Enriched Cultures from Fetal-Rat Parietal Bone”Molecular and Cellular Biology11(1):250-258 (1991).
Cooper et al., “Detection and Quantification of Phosphotyrosine in Proteins”Methods in Enzymology99:387-402 (1983).
Featherstone and Russell, “Fission yeast p107voolmitotic inhibitor is a tyrosine/serine kinase”Nature349:808-811 (1991).
Feng and Doolittle, “Progressive Sequence Alignment as a Prerequisite to Correct Phylogenetic Trees”J. Mol. Evol.25:351-360 (1987).
Fitch and Margoliash, “Construction of Phylogenetic Trees”Science155:279-284 (1967).
Gearing et al., “Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor”EMBO Journal8(12):3667-3676 (1989).
Georgi et al., “daf-1, aC. elegansGene Controlling Dauer Larva Development, Encodes a Novel Receptor Protein Kinase”Cell61:635-645 (1990).
Hanks and Quinn, “Protein Kinase Catalytic Domain Sequence Database: Identification of Conserved Features of Primary Structure and Classification of Family Members”Methods in Enzymology200:38-62 (1991).
Hanks et al., “The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains”Science241:42-52 (1988).
Hino et al., “Characterization of Cellular Receptors for Erythroid Differentiation Factor on Murine Erythroleukemia Cells”J. Biol. Chem.264(17):10309-10314 (1989).
Howell et al., “STY, a Tyrosine-Phosphorylating Enzyme with Sequence Homology to Serine/Threonine Kinases”Molecular and Cellular Biology11(1):568-572 (1991).
Kintner, C., “Effects of Altered Expression of the Neural Cell Adhesion Molecule, N-CAM, on Early Neural Development in Xenopus Embryos”Neuron1:545-555 (1988).
Kintner and Melton, “Expression of Xenopus N-CAM RNA in ectoderm is an early response to neural induction”Development99:311-325 (1987).
Kondo et al., “Identification of the Two Types of Specific Receptor for Activin/EDF Expressed on Friend Leukemia and Embryonal Carcinoma Cells”Biochem. Biophys. Res. Comm.161(3):1267-1272 (1989).
Kozak M., “An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs”Nucleic Acids Research15:8125-8148 (1987).
Krieg and Melton, “In Vitro RNA Synthesis with SP6 RNA Polymerase”Methods in Enzymology155:397-415 (1987).
Kyte and Doolittle, “A Simple Method for Displaying the Hydropathic Character of a Protein”,J. Mol. Biol.157:105-132 (1992).
Mason et al., “Activin B: Precursor Sequences, Genomic Stucture and in Vitro Activities”Molecular Endocrinology3(9):1352-1358 (1989).
Massague et al., “TGF-&bgr; Receptors and TGF-&bgr; Binding Proteoglycans: Recent Progress in Identifying Their Funtional Properties”Ann. N. Y. Acad. Sci.593:59-73 (1990).
Mathews and Vale, “Expression Cloning of an Activin Receptor, a Predicted Transmembrane Serine Kinase”Cell65:973-982 (1991).
Melton et al., “Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter”Nucleic Acids Research12:7035-7056 (1984).
Mine et al., “Stimulation of Glucose Production by Activin-A in Isolated Rat Hepatocytes”Endocrinology125(2):586-591 (1989).
Munson and Rodbard, “Ligand: A Versatile Computerized Approach for Charaterization of Ligand-Binding Systems”Analytical Biochemistry107:220-239 (1980).
Nakamura et al., “Association of Activin-Binding Protein with Cell Surface”Abstracts; J. Cell Biol111:351a (1990).
Pearson and Lipman, “Improved tools for biological sequence comparison”Proc. Natl. Acad. Sci. USA85:2444-2448 (1988).
Saito et al., “Production of Activin-Binding Protein by Rat Granulosa Cells in vitro”Bi
Mathews Lawrence W.
Tsuchida Kunihiro
Vale, Jr. Wylie W.
Brumback Brenda
Foley & Lardner
Li Ruixiang
Reiter Stephen E.
The Salk Institute for Biological Studies
LandOfFree
Methods of screening for compounds that bind to activin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of screening for compounds that bind to activin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of screening for compounds that bind to activin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3314514